Abbott Laboratories News Headlines

ABT 
$42.46
*  
0.03
0.07%
Get ABT Alerts
*Delayed - data as of Oct. 24, 2014  -  Find a broker to begin trading ABT now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Update: Abbott To Invest $60 Million In An Intraocular Lens Plant In Malaysia
9/15/2014 3:00:00 PM - Seeking Alpha


Notable ETF Outflow Detected - SSO, MMM, ABT, ABBV
9/15/2014 1:04:55 PM - BNK Invest


Abbott Begins ABSORB IV Trial To Test Quality Of Life & Cost Savings Of BVS
9/15/2014 9:51:00 AM - RTT News


Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session - Tale of the Tape
9/15/2014 9:18:00 AM - Zacks.com


Abbott's Dissolving Heart Device Shows Positive Study Results
9/14/2014 4:25:00 PM - RTT News


AbbVie's Humira Positive in Phase III Skin Disease Study - Analyst Blog
9/12/2014 5:05:00 PM - Zacks.com


Abbott Labs (ABT) to Repurchase Shares for $3B - Analyst Blog
9/12/2014 4:50:00 PM - Zacks.com


Daily Dividend Report: INTC, ABT, TJX, BXP, RL, SLG, HUN, CBI, DRI, OCR
9/12/2014 1:01:30 PM - BNK Invest


Stocks And Funds With The Most Size (Small-Cap) Risk
9/12/2014 8:04:00 AM - Seeking Alpha


Evaluating GlaxoSmithKline's Intrinsic Value
9/12/2014 7:38:00 AM - Seeking Alpha


Mylan to Acquire U.S. Rights to Arixtra for up to $300M - Analyst Blog
9/11/2014 5:20:00 PM - Zacks.com


FDA Approves Orexigen Therapeutics Inc.'s Goldilocks Obesity Drug
9/11/2014 4:46:01 PM - Motley Fool


Abbott Announces New $3 Bln Stock Buyback Program
9/11/2014 2:30:00 PM - RTT News


Abbott Is Getting Expensive On A Fundamental Basis
9/11/2014 10:13:00 AM - Seeking Alpha


ACWI, RXL: Big ETF Inflows
9/9/2014 12:08:49 PM - BNK Invest


FTC Sues AbbVie For Illegally Blocking Generic Version Of AndroGel
9/9/2014 4:00:00 AM - RTT News


What Price Dividend Aristocracy? Assessing The Dividend Aristocrats And The NOBL ETF (Part 2)
9/8/2014 3:57:00 PM - Seeking Alpha


Noteworthy ETF Outflows: SSO, MMM, ABT, ABBV
9/8/2014 11:41:43 AM - BNK Invest


What Price Dividend Aristocracy? The Dividend Aristocrats And Their Fair Values (Part 1)
9/5/2014 8:44:00 PM - Seeking Alpha


Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark - Analyst Blog
9/5/2014 4:35:00 PM - Zacks.com


The Market Appears Overvalued: Four Strategies For Bear-Proofing Your Porfolio
9/5/2014 12:01:00 PM - Seeking Alpha


Google's Calico in $500M Joint Venture with AbbVie - Analyst Blog
9/4/2014 4:38:00 PM - Zacks.com


Sweet News For ABT, Adherex To Change Name, FLXN's Work In Progress, INFI Rises
9/4/2014 1:01:00 AM - RTT News


Abbott Receives CE Mark For Its FreeStyle Libre Flash Glucose Monitoring System
9/3/2014 9:36:00 AM - RTT News


Abbott Laboratories: An Emerging Markets Growth Play With Increasing Dividends
9/3/2014 6:00:00 AM - Seeking Alpha